Miramontes Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$953K Sell
3,643
-25
-0.7% -$6.41K 0.29% 52
2026
Q2
$923K Buy
3,668
+104
+3% +$22.4K 0.29% 54
2026
Q1
$775K Sell
3,564
-67
-2% -$14.9K 0.27% 57
2025
Q4
$830K Buy
+3,631
New +$827K 0.28% 54

Other funds holding ABBV

Miramontes Capital's ABBV Position: Q3 2026 in Review

Miramontes Capital reduced its AbbVie (ABBV) stake by 0.68% in Q3 2026, selling an estimated $6.41K and leaving 3,643 shares worth $953K. The position accounts for 0.29% of the portfolio, ranked #52.

Miramontes Capital first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Miramontes Capital held 3,643 shares of AbbVie worth $953K as of Q3 2026.
  • Miramontes Capital sold 25 AbbVie shares in Q3 2026, an estimated $6.41K.
  • AbbVie made up 0.29% of Miramontes Capital's portfolio in Q3 2026, its #52 holding.
  • Miramontes Capital first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Miramontes Capital's 13F filing for Q3 2026, filed 19 Oct 2026.